In Q4 2024, Sulfamethazine prices showed a mixed trend across regions. In North America, prices initially saw a decline due to weak demand from key sectors like agriculture and pharmaceuticals, which were affected by ongoing economic uncertainty. However, as the quarter progressed, demand picked up, particularly in the agricultural sector, leading to a recovery in prices. Production constraints and a more favorable economic environment helped support this upward trend in the latter half of the quarter.
In the APAC region, prices followed a downward trajectory, largely driven by soft demand from agriculture and livestock industries. Despite some stability in the pharmaceutical sector, it wasn't enough to offset the reduction in consumption from other key sectors. Supply chain disruptions and economic challenges also played a role in putting downward pressure on prices.
In Europe, Sulfamethazine prices started lower due to weak demand and high logistical costs, but towards the end of the quarter, prices began to recover. The rebound in agricultural and veterinary demand, combined with rising raw material costs, helped support price increases.